Implementation / NHS Adoption / Dissemination

It is important that the process by which the research will enter the health and/or social care environment is understood. Also, how the results of the project will be communicated (disseminated) and introduced into the healthcare system. Consideration should be given to how the technology will be able to be adopted and implemented longer term. Further, the challenges (future barriers to uptake) for getting your research implemented in terms of acceptability, accessibility and feasibility should be identified and mitigated against.

WPX Implementation, Adoption and Dissemination | Months xxx | Cost £xK | Lead: XXX

In order to support NHS adoption, XXX will help with identification and intelligence on the relevant patient pathways and their key stakeholders. Early engagement with stakeholders will facilitate the mapping of the innovation to all relevant NHS pathways ensuring barriers to adoption within the NHS are identified early. Support will also include identification of appropriate funding mechanisms and procurement routes to begin engagement with finance managers, budget holders and decision makers.

A device value proposition (VP) will be developed to inform and support the business case development for adoption of the xxxx device and software in the NHS. The VP will include recommendations on the evidence base needed for NHS adoption, review the enablers and barriers for NHS adoption and will articulate the potential for cost savings that might be realised through deployment of the xxxx in the relevant patient pathways. The work will include identification of relevant patient pathways, identification of all necessary data needed for health economic modelling, and a review of clinical trial outcomes needed to support the device claims. The VP and Health Economic evaluation and modelling could incorporate data from the clinical trial when it becomes available.

Special attention will be given to disseminating the study findings to participants involved in the project and clinical study and to relevant user groups. The public involvement lead/group will aid dissemination by attending relevant conferences and meetings to be able to promote the technology to patient audiences as well as more clinically based presentations as appropriate.

Early identification and engagement of stakeholders, end users and opinion leaders will be undertaken as part of our implementation, adoption, and dissemination strategies.

Publications in key journals and open access publication, presenting at national and international conferences and use of social media and blogs will also maximise dissemination of results. Study participants will be informed through reports/publications.

Deliverables
D1 Stakeholder mapping analysis and report
D2 Implementation plan for future research and clinical practice
D3 Draft adoption plan for inclusion in the business plan
D4 Produce full business case to include NHS implementation and adoption strategy
D5 Active social media, presentations and open access publications submitted by month xx

Milestones
M1 Stakeholders/Champions identified by month xx
M2 Clinical implementation and adoption strategies completed by month xx

Planning for future adoption of technology into the NHS - NHS MedTech Funding Mandate policy